← Back to Clinical Trials
Recruiting NCT07283458

NCT07283458 Assessment of Language Comprehension and Learning in Children Attending Child Psychiatry Services (TICOALA-SOINS)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07283458
Status Recruiting
Phase
Sponsor Centre Hospitalier St Anne
Condition Typical Development
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2026-03-19
Primary Completion 2028-03-19

Eligibility & Interventions

Sex All sexes
Min Age 3 Years
Max Age 7 Years
Study Type INTERVENTIONAL
Interventions
TICOALA

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 50 participants in total. It began in 2026-03-19 with a primary completion date of 2028-03-19.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Language is central to children's cognitive, emotional, and social development, and language difficulties are a frequent reason for consultation in child psychiatry, often co-occurring with psychiatric disorders. Yet, systematic language assessment is rarely possible due to the limited availability of speech-language therapists in these services. The TICOALA tool (Interactive Test of Language Comprehension and Learning on tablet) offers a quick and engaging way to evaluate lexical and syntactic comprehension and word learning. This study aims to assess its acceptability among children aged 3-7 attending a child psychiatry service in Paris, as well as among clinicians and parents. Secondary goals include testing the feasibility of a larger study, describing children's language skills, and examining how these relate to clinical and background variables.

Eligibility Criteria

Inclusion Criteria: * Children (boys or girls) aged 3-7 years * Consulting in the child psychiatry service * Enrolled in a French-speaking school Exclusion Criteria: * Inability to use the tablet-based TICOALA tool due to severe sensory (blindness, deafness), motor, or intellectual impairment * Refusal of the child or parents/legal guardians to participate * Child not affiliated with the French social security system

Contact & Investigator

Central Contact

Khaoussou SYLLA, Dr

✉ K.SYLLA@ghu-paris.fr

📞 +33145658486

Frequently Asked Questions

Who can join the NCT07283458 clinical trial?

This trial is open to participants of all sexes, aged 3 Years or older, up to 7 Years, studying Typical Development. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07283458 currently recruiting?

Yes, NCT07283458 is actively recruiting participants. Contact the research team at K.SYLLA@ghu-paris.fr for enrollment information.

Where is the NCT07283458 trial being conducted?

This trial is being conducted at Paris, France.

Who is sponsoring the NCT07283458 clinical trial?

NCT07283458 is sponsored by Centre Hospitalier St Anne. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology